Related references
Note: Only part of the references are listed.In vitro activity of tigecycline and 10 other antimicrobials against clinical isolates of the genus Corynebacterium
R. Fernandez-Roblas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
The isolation of Corynebacterium coyleae from clinical samples:: clinical and microbiological data
M. I. Fernandez-Natal et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Differences in potential for selection of clindamycin-resistant mutants between inducible erm(A) and erm(C) Staphylococcus aureus genes
Claire Daurel et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Nosocomial outbreak of Corynebacterium striatum infection in patients with chronic obstructive pulmonary disease
Feliu Renom et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
In vitro activity of linezolid and 12 other antimicrobials against coryneform bacteria
Jose-Luis Gomez-Garces et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Staphylococcus efflux msr(A) gene characterized in Streptococcus, Enterococcus, Corynebacterium, and Pseudomonas isolates
KK Ojo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Predominance of 23S rRNA mutants among non-erm, non-mef macrolide-resistant clinical isolates of Streptococcus pneumoniae collected in the United States in 1999-2000
TA Davies et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates
MM Daly et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
In vitro activities of daptomycin, vancomycin, quinupristin-dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates
EJC Goldstein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Characteristics of rare or recently described Corynebactetium species recovered from human clinical material in Canada
KA Bernard et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae
A Canu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Inducible macrolide resistance in Corynebacterium jeikeium
AE Rosato et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage
A Tait-Kamradt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
